Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Optimal vaccination with time-varying based on immunity barrier in Hunan Province, China

Xiaohao Guo, Ziyan Liu, Shiting Yang, Zeyu Zhao, Yichao Guo, Guzainuer Abudurusuli, Jia Rui, Yao Wang, Shanlu Zhao, Ge Zeng, Shixiong Hu, Kaiwei Luo, View ORCID ProfileTianmu Chen
doi: https://doi.org/10.1101/2022.03.02.22271610
Xiaohao Guo
1State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen City 361102, Fujian Province, People’s Republic of China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ziyan Liu
2Hunan Provincial Center for Disease Control and Prevention, 405 Furong Middle Road Section One, Kaifu District, Changsha City 410001, Hunan Province, People’s Republic of China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shiting Yang
1State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen City 361102, Fujian Province, People’s Republic of China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zeyu Zhao
1State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen City 361102, Fujian Province, People’s Republic of China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yichao Guo
1State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen City 361102, Fujian Province, People’s Republic of China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guzainuer Abudurusuli
1State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen City 361102, Fujian Province, People’s Republic of China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jia Rui
1State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen City 361102, Fujian Province, People’s Republic of China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yao Wang
1State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen City 361102, Fujian Province, People’s Republic of China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shanlu Zhao
2Hunan Provincial Center for Disease Control and Prevention, 405 Furong Middle Road Section One, Kaifu District, Changsha City 410001, Hunan Province, People’s Republic of China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ge Zeng
2Hunan Provincial Center for Disease Control and Prevention, 405 Furong Middle Road Section One, Kaifu District, Changsha City 410001, Hunan Province, People’s Republic of China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shixiong Hu
2Hunan Provincial Center for Disease Control and Prevention, 405 Furong Middle Road Section One, Kaifu District, Changsha City 410001, Hunan Province, People’s Republic of China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: 379788967@qq.com 87616498@qq.com chentianmu@xmu.edu.cn 13698665@qq.com
Kaiwei Luo
2Hunan Provincial Center for Disease Control and Prevention, 405 Furong Middle Road Section One, Kaifu District, Changsha City 410001, Hunan Province, People’s Republic of China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: 379788967@qq.com 87616498@qq.com chentianmu@xmu.edu.cn 13698665@qq.com
Tianmu Chen
1State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen City 361102, Fujian Province, People’s Republic of China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tianmu Chen
  • For correspondence: 379788967@qq.com 87616498@qq.com chentianmu@xmu.edu.cn 13698665@qq.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

The current outbreak of novel coronavirus disease 2019 (COVID-19) is already causing a serious disease burden worldwide, this paper analyzed data of a delta variant Covid-19 outbreak in Hunan, China, and proposed an optimal dose-wise dynamical vaccinating process based on local contact pattern and vaccine coverage that minimize the accumulative cases in a certain future time interval. The optimized result requires an immediate vaccination to that none vaccinated at age group 30 to 39, which is coherent to the prevailing strategies. The dose-wise optimal vaccinating process can be directive for countries or regions where vaccines are not abundant. We recommend that vaccination should be further intensified to increase the coverage of booster shots, thus effectively reducing the spread of COVID-19.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was funded by the Bill & Melinda Gates Foundation (INV-005834), and the Impact on prevention and control COVID-19 of vaccination intention and effectiveness: a modelling study(2021YFC2301604).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Emails:

    Xiaohao Guo: guo3.1415926536{at}qq.com

    Ziyan Liu:1715773383{at}qq.com

    Shiting Yang: yst3393{at}163.com

    Zeyu Zhao: 381597586{at}qq.com

    Yichao Guo: 564931539{at}qq.com

    Guzainuer Abudurusuli: 748693650{at}qq.com

    Jia Rui: 2931438521{at}qq.com

    Yao Wang: 812304436{at}qq.com

    Shanlu Zhao: 1654919009{at}qq.com

    Ge Zeng: 244870450{at}qq.com

    Shixiong Hu: 379788967{at}qq.com

    Kaiwei Luo: 87616498{at}qq.com

    Tianmu Chen: 13698665{at}qq.com

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted March 03, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Optimal vaccination with time-varying based on immunity barrier in Hunan Province, China
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Optimal vaccination with time-varying based on immunity barrier in Hunan Province, China
Xiaohao Guo, Ziyan Liu, Shiting Yang, Zeyu Zhao, Yichao Guo, Guzainuer Abudurusuli, Jia Rui, Yao Wang, Shanlu Zhao, Ge Zeng, Shixiong Hu, Kaiwei Luo, Tianmu Chen
medRxiv 2022.03.02.22271610; doi: https://doi.org/10.1101/2022.03.02.22271610
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Optimal vaccination with time-varying based on immunity barrier in Hunan Province, China
Xiaohao Guo, Ziyan Liu, Shiting Yang, Zeyu Zhao, Yichao Guo, Guzainuer Abudurusuli, Jia Rui, Yao Wang, Shanlu Zhao, Ge Zeng, Shixiong Hu, Kaiwei Luo, Tianmu Chen
medRxiv 2022.03.02.22271610; doi: https://doi.org/10.1101/2022.03.02.22271610

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (243)
  • Allergy and Immunology (525)
  • Anesthesia (125)
  • Cardiovascular Medicine (1435)
  • Dentistry and Oral Medicine (220)
  • Dermatology (158)
  • Emergency Medicine (292)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (589)
  • Epidemiology (10334)
  • Forensic Medicine (6)
  • Gastroenterology (533)
  • Genetic and Genomic Medicine (2654)
  • Geriatric Medicine (255)
  • Health Economics (499)
  • Health Informatics (1744)
  • Health Policy (791)
  • Health Systems and Quality Improvement (681)
  • Hematology (269)
  • HIV/AIDS (571)
  • Infectious Diseases (except HIV/AIDS) (12119)
  • Intensive Care and Critical Care Medicine (650)
  • Medical Education (276)
  • Medical Ethics (83)
  • Nephrology (291)
  • Neurology (2483)
  • Nursing (145)
  • Nutrition (381)
  • Obstetrics and Gynecology (497)
  • Occupational and Environmental Health (569)
  • Oncology (1335)
  • Ophthalmology (403)
  • Orthopedics (153)
  • Otolaryngology (239)
  • Pain Medicine (172)
  • Palliative Medicine (51)
  • Pathology (345)
  • Pediatrics (786)
  • Pharmacology and Therapeutics (334)
  • Primary Care Research (297)
  • Psychiatry and Clinical Psychology (2421)
  • Public and Global Health (5032)
  • Radiology and Imaging (902)
  • Rehabilitation Medicine and Physical Therapy (536)
  • Respiratory Medicine (688)
  • Rheumatology (309)
  • Sexual and Reproductive Health (257)
  • Sports Medicine (246)
  • Surgery (300)
  • Toxicology (45)
  • Transplantation (141)
  • Urology (108)